The Triple-Hormone Weight Drug Beating Every Number — With One Buried Catch

The Triple-Hormone Weight Drug Beating Every Number — With One Buried Catch

Semaglutide, the active compound in Ozempic, works by targeting a single hormone receptor, GLP-1. Tirzepatide, found in Mounjaro, added a second (GIP). Now retatrutide hits three — adding glucagon to the mix, which is the counterintuitive part. Most people know glucagon as the hormone that raises blood sugar, which sounds like the last thing you'd want in a weight-loss drug. But at the receptor level, glucagon also drives energy expenditure and fat oxidation. The mechanism isn't just "suppress appetite harder" — it's "burn more on top of eating less." The Phase 3 TRIUMPH-4 topline results appear to reflect that: an average of 28.7% body weight reduction, which puts it beyond even tirzepatide territory.

But here's the detail buried beneath the headline number. At the 12 mg dose — the highest tested — roughly 20.9% of participants reported dysesthesia, a term for altered or uncomfortable skin sensations, compared to just 0.7% on placebo. That's a signal that did not appear in Phase 2. Discontinuations from dysesthesia were reportedly low, and it's being tracked across the remaining TRIUMPH trials, but a side effect emerging only at the top dose and only at Phase 3 scale is exactly the kind of thing that deserves more attention than it's getting. A few critical caveats before this gets forwarded around: retatrutide has no FDA-approved label and no approved dose. The 28.7% figure comes from a sponsor announcement — not a peer-reviewed paper. And anything sold online as "retatrutide" is not the trial compound; identity and dosing cannot be assumed from these numbers.

Gobble's Take: A drug that makes your body burn fat and eat less is genuinely novel — but a side effect that hid through all of Phase 2 and appeared in 1 in 5 people at the top dose is worth watching harder than the headline weight-loss number.

Source: r/Biohacking

The "30 Plants a Week" Rule Has a Research Problem

The 30-plants-a-week target has become one of those wellness numbers that feels official by repetition — cited in articles, podcasts, and nutrition circles as the threshold for a healthy gut microbiome. But microbiome researchers, including a PhD candidate at APC Microbiome Ireland (one of the world's leading microbiome research centers), say the evidence behind that specific number is shakier than the confident tone of most coverage suggests.

The figure traces back to a 2018 study from the American Gut Project — now called the Microsetta Initiative — a large ongoing database of volunteer gut samples paired with diet questionnaires. Researchers found that people eating more than 30 plant types per week had higher levels of gut bacteria associated with short-chain fatty acids (SCFAs), compounds linked to a range of beneficial health effects including gut lining support. That sounds compelling until you look at the design: the study compared people eating more than 30 against people eating fewer than 10, skipping everything in between. What happens at 15 plants? At 22? The study doesn't say. It also didn't control for other dietary habits, lifestyle factors, or the fact that the sample skewed heavily toward health-conscious, affluent Western participants — a population whose microbiomes may not reflect the global range.

The experts quoted in the underlying reporting are careful not to dismiss plant diversity — they broadly support it. But they distinguish between "eating a wide variety of plants is good for your microbiome" (well-supported) and "30 is the specific threshold that matters" (much less so). Other variables, including total fiber intake, alcohol consumption, exercise, and sleep, also shape microbiome diversity in ways the 30-plant framing doesn't capture.

Gobble's Take: The 30-plant target is probably a useful nudge in the right direction, but if you're tracking it like a macronutrient goal, you've turned a rough research signal into a precision metric it was never designed to be.

Source: r/Health

In Case You Missed It

Yesterday's top stories:

• Your Gut Bacteria Know How Old You Really Are — And They Might Be Able to Change the Answer
• Quitting Ozempic Sends Most Weight Back — Two New Trials Found Ways to Fight the Rebound
• Lenny Kravitz Looks 25 at 60 — But the Biohacking Community Isn't Buying the Raw-Diet Credit